🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Platelet-Rich Plasma (PRP) has been banned in competitive athletes because ...
Status
Completed
Location
New York University Langone Orthopedic Hospital
Start Date
2010-07
Trial ID
NCT01200875
Treatments Being Tested
This is an open-label, single-center, Phase II trial designed to estimate i...
Status
Unknown
Location
Istituto Clinico Humanitas
Start Date
2020-01-30
Trial ID
NCT04435977
Treatments Being Tested
Trial investigates the benefits and harms of Levodopa /Carbidopa 100/25mg c...
Status
Active Not Recruiting
Location
Kantonsspital Aarau, Neurozentrum
Start Date
2019-06-14
Trial ID
NCT03735901
Treatments Being Tested
This is a single arm, open label study of up to 24 high risk prostate cance...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2012-01
Trial ID
NCT01572701
Treatments Being Tested
Giving medications to children can be confusing; studies have shown that ca...
Status
Terminated
Location
Columbia University Medical Center
Start Date
2011-02
Trial ID
NCT01294501
Treatments Being Tested
This observational study will evaluate the efficacy and safety of bevacizum...
Status
Completed
Location
Clinique Esquirol Saint Hilaire
Start Date
2010-09-30
Trial ID
NCT01343901
Treatments Being Tested
The goal of this clinical trial is to learn whether the antibiotic ceftoloz...
Status
Terminated
Location
Weill Cornell Medicine
Start Date
2023-01-10
Trial ID
NCT04673175
Treatments Being Tested
Summary In patients with prostate cancer (PC) who have only biochemically ...
Status
Unknown
Location
Copenhagen University hospital, Rigshospitalet
Start Date
2009-02
Trial ID
NCT03119857
Treatments Being Tested
This trial is conducted in South Africa. The aim of this trial is to invest...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2002-03-20
Trial ID
NCT01486381
Treatments Being Tested
Study Hypothesis: Preterm infants administered weekly Darbe during the neon...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2017-09-20
Trial ID
NCT03169881
Treatments Being Tested